/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual...

Related Keywords

Dublin , Ireland , Waltham , Massachusetts , United States , Ohio , Athlone , Westmeath , Marisa Borgasano , Sandy Coombs , Aripiprazole Lauroxil , Craig Hopkinson , Alkermes , Research Development At Alkermes , Alkermes Pharma Ireland , Us National Health , Wellness Survey Data , Nasdaq , Psych Congress , Mental Health , Alkermes Inc , Poster Presentations Highlight Company , Broad Research Commitment , Serious Mental Illness , Annual Psych Congress , Chief Medical Officer , Executive Vice President , Patient Perspective , In Depth Qualitative , Month Formulation , Acute Schizophrenia , Post Hoc Analysis , Key Characteristics , Atypical Long Acting Injectable , Antipsychotic Aripiprazole Lauroxil , Samidorphan Effects , Weight Gain , Bipolari Disorder , Humanistic Outcomes , Matched Analysis , Wellness Survey , Healthcare Resource Utilization Following , Treatment With , Real World Assessment , Patients With Schizophrenia , Baseline Demographics , Clinical Characteristics From , Treatment Patterns From , Observational Study , Outcomes From , Alcohol Use , Opioid Antagonists , Clinical Utility , Prescribing Information , Adverse Reactions , Elderly Patients , Dementia Related Psychosis , Boxed Warning , Severe Opioid Withdrawal , Physiologically Dependent , Life Threatening Opioid Overdose , Malignant Syndrome , Systemic Symptoms , Motor Impairment , Temperature Dysregulation , Combination Treatment , Mixed Episodes , Extended Release Injectable Suspension , Including Stroke , Medication Errors , Diabetes Mellitus , Temperature Regulation , Observed Adverse Reactions , Site Reactions , Alkermes Pharma Ireland Limited , Alkermes Plc ,